Alzheimer's disease (AD) is a neurodegenerative condition characterized by a gradual
decline in cognitive functions. Currently, there are no effective treatments for AD …

Background Advancement in screening tools accessible to the general population for the
early detection of Alzheimer's disease (AD) and prediction of its progression is essential for …

Objective This study assessed the relationship between speech and language impairment
and outcome in a multicenter cohort of isolated/idiopathic rapid eye movement (REM) sleep …

Alzheimer's disease (AD) is a common cause of dementia, characterised by cerebral
amyloid-β deposition, pathological tau and neurodegeneration. The prodromal stage of AD …

The rapid advance of generative AI is reshaping the strategic vision for R&D across
industries. The unique challenges of pharmaceutical R&D will see applications of generative …

Compared with other health disciplines, there is a stagnation in technological innovation in
the field of clinical neuropsychology. Traditional paper-and-pencil tests have a number of …

Background Digital cognitive assessment is becoming increasingly widespread in ageing
research and care, especially since the COVID-19 pandemic. Remote online collection …

Background: In Japan, individuals with mild COVID-19 illness previously required to be
monitored in designated areas and were hospitalized only if their condition worsened to …

We propose a Perceiver-based sequence classifier to detect abnormalities in speech
reflective of several neurological disorders. We combine this classifier with a Universal …

Background Alzheimer's disease (AD) is a progressive neurologic disease and the most
common cause of dementia. Classic pathology in AD is characterized by inflammation …